We are live on ! Find out more
RCEL icon

Avita Medical

79 hedge funds and large institutions have $61.9M invested in Avita Medical in 2026 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

272% more capital invested

Capital invested by funds: $16.6M → $61.9M (+$45.3M)

164% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 11

100% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 13

18% more funds holding

Funds holding: 6779 (+12)

3.06% more ownership

Funds ownership: 15.82%18.88% (+3.1%)

Holders
79
Holders Change
+12
Holders Change %
+17.91%
% of All Funds
0.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
29
Reduced
11
Closed
13
Calls
$155M
Puts
Net Calls
+$155M
Net Calls Change
+$154M

RCEL Hedge Fund Activity: Q1 2026 in Review

79 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q1 2026, worth a combined $61.9M — up 272% from $16.6M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RCEL positions and 13 closed out — a net gain of 13 holders — while 29 added to existing stakes and 11 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $2.29M. The largest seller was Bridgeway Capital Management, cutting an estimated $368K.

  • 79 institutional investors held Avita Medical (RCEL) as of Q1 2026, up from 67 in Q4 2025.
  • Funds reported $61.9M of Avita Medical stock for Q1 2026, up 272% quarter-over-quarter.
  • 26 funds opened new Avita Medical positions in Q1 2026 and 13 closed out, a net change of +13 holders.
  • The largest Avita Medical buyer in Q1 2026 was OrbiMed, an estimated $2.29M added.
  • The largest Avita Medical seller in Q1 2026 was Bridgeway Capital Management, an estimated $368K sold.

Based on aggregated 13F filings for Q1 2026.